Study of ABT-888 in Combination With Bortezomib and Dexamethasone in Patients With Relapsed Refractory Myeloma
Clinical trial NCT01495351 · COMPLETED
Trial details
- NCT number
- NCT01495351
- Sponsor
- AHS Cancer Control Alberta
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-01
- Primary completion
- 2015-02-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.